Early Access — free while we kick the tires
EdgarHawk

Meyer Andrew Hollman

Chief Business Officer

Officer
1 filing analyzed · 1 company · Latest 2024-09-27

Companies

Company Buys Sells Direction
Janux Therapeutics, Inc. JANX 0 2 Net selling

Activity

September 2024
high
Sell
50,000 shares
$2,297,755
Significance 6/10

Chief Business Officer sold 50,000 JANX shares ($2.3M) at $45.96; stock down 28.6% from 52-week high; company unprofitable.

Meyer Andrew Hollman, Chief Business Officer, sold 50,000 shares (representing a 42.5% reduction of his pre-transaction holdings of 117,592 shares) on 2024-09-27 at $45.96 per share, generating $2,297,755.00 in proceeds. The sale occurred while the stock trades at $46.25, down 28.6% from its 52-week high of $64.78, and reflects a company with negative fundamentals: quarterly revenue of $8,897,000.00 paired with a quarterly net loss of $5,959,000.00, annual revenue decline of 6.1%, and full-year unprofitability. The substantial reduction in holdings by a senior executive at a loss-making enterprise with declining top-line growth presents a material cash realization event worth monitoring for its signal regarding near-term business trajectory or capital allocation priorities.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access